Is weight gain a potential side effect of Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lexapro and Weight Gain

Yes, weight gain is a potential side effect of Lexapro (escitalopram), though it tends to cause less weight gain than many other antidepressants.

Weight Effects of Escitalopram

  • According to the FDA drug label, patients treated with escitalopram in controlled trials did not differ from placebo-treated patients with regard to clinically important changes in body weight 1
  • However, clinical guidelines recognize that selective serotonin reuptake inhibitors (SSRIs) like escitalopram can be associated with weight gain, though the effect varies between medications in this class 2, 3
  • Escitalopram typically causes minimal weight change in the short term, with an average increase of only 0.14 kg (0.05-point BMI increase) over 12 weeks of treatment 4

Comparative Weight Effects Among Antidepressants

  • Within the SSRI class, paroxetine has the highest risk of weight gain, while fluoxetine and sertraline are typically associated with initial weight loss followed by weight neutrality with long-term use 3, 5
  • Bupropion is the only antidepressant consistently shown to promote weight loss through appetite suppression and reduced food cravings 3
  • Tricyclic antidepressants (TCAs) like nortriptyline cause significantly more weight gain than escitalopram, with studies showing an average of 1.2 kg gain (0.44-point BMI increase) after 12 weeks of treatment 4

Risk Factors and Monitoring

  • Weight gain with antidepressants can be influenced by individual factors:
    • Patients who are underweight at baseline may gain more weight during treatment 4
    • Patients who are obese at baseline typically do not experience additional weight gain during escitalopram treatment 4
  • Regular monitoring of weight is recommended during escitalopram treatment 3
  • Weight gain with escitalopram appears to be less pronounced than with other psychotropic medications such as certain antipsychotics, mood stabilizers, and tricyclic antidepressants 3, 6

Clinical Implications and Management

  • Weight gain can significantly impact treatment adherence - many patients find weight gain so intolerable that they may discontinue treatment even if the medication is effective 7
  • For patients with significant concerns about weight gain, consider:
    • Choosing a more weight-neutral option like fluoxetine or a weight-loss promoting option like bupropion if clinically appropriate 3
    • Implementing dietary counseling and physical activity recommendations at treatment initiation 2, 6
  • Be aware that medications for comorbid conditions may also contribute to weight gain and should be minimized when possible 2

Important Caveats

  • Weight gain during antidepressant treatment is not simply a reversal of symptomatic weight loss and is usually perceived as an undesired adverse effect by patients 4
  • Even after patients stop taking the medication, weight gained during therapy may be difficult to lose, making prevention the best approach 7
  • The pharmacologic mechanisms underlying weight gain with antidepressants are poorly understood but may involve effects on appetite regulation in the hypothalamus and alterations in metabolic rate 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Citalopram and Weight Gain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Changes in body weight during pharmacological treatment of depression.

The international journal of neuropsychopharmacology, 2011

Guideline

Medication-Related Weight Changes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Weight gain associated with use of psychotropic medications.

The Journal of clinical psychiatry, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.